British Telecommunications News - A3K8U3

- (25-NSE)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 25 NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION...

- Quarterly Report (10-Q)

FORM 10-Q SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section...

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy...

MEDTOX Announces Settlement With Putative Class Action Plaintiffs Regarding Acquisition by LabCorp

ST. PAUL, Minn., July 20, 2012 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced that...

LabCorp Misses, Narrows Guidance - Analyst Blog

Laboratory Corporation of America Holdings (LH) reported earnings per share (“EPS”) of $1.56 in the second quarter of fiscal 2012...

Earnings Preview: LabCorp - Analyst Blog

Laboratory Corporation of America Holdings (LH) is scheduled to release its second quarter fiscal 2012 earnings on Thursday, July 19, 2012...

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT...

LabCorp’s Acquisition of MEDTOX Clears Antitrust Approval

Laboratory Corporation of America® Holdings (NYSE: LH) today announced that the Federal Trade Commission has granted early...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section...

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section...

MEDTOX Scientific Announces Second Quarter Results

ST. PAUL, Minn., July 12, 2012 (GLOBE NEWSWIRE) -- MEDTOX Scientific, Inc. (Nasdaq:MTOX) today announced...

- Amended Statement of Ownership (SC 13G/A)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2...

- Amended Statement of Ownership (SC 13G/A)

Securities and Exchange Commission Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3) Medtox...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

British Telecommunications (A3K8U3)

Professional-Grade Tools, for Individual Investors.

A3K8U3 News

- (25-NSE)

- Quarterly Report (10-Q)

- Current report filing (8-K)

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

MEDTOX Announces Settlement With Putative Class Action Plaintiffs Regarding Acquisition by LabCorp

LabCorp Misses, Narrows Guidance - Analyst Blog

Earnings Preview: LabCorp - Analyst Blog

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

LabCorp’s Acquisition of MEDTOX Clears Antitrust Approval

- Current report filing (8-K)

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

MEDTOX Scientific Announces Second Quarter Results

- Amended Statement of Ownership (SC 13G/A)

- Amended Statement of Ownership (SC 13G/A)

A3K8U3 Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

British Telecommunications (A3K8U3) News

British Telecommunications (A3K8U3)

Professional-Grade Tools, for Individual Investors.

A3K8U3 News

- (25-NSE)

- Quarterly Report (10-Q)

- Current report filing (8-K)

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

MEDTOX Announces Settlement With Putative Class Action Plaintiffs Regarding Acquisition by LabCorp

LabCorp Misses, Narrows Guidance - Analyst Blog

Earnings Preview: LabCorp - Analyst Blog

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

LabCorp’s Acquisition of MEDTOX Clears Antitrust Approval

- Current report filing (8-K)

- Additional Proxy Soliciting Materials (definitive) (DEFA14A)

MEDTOX Scientific Announces Second Quarter Results

- Amended Statement of Ownership (SC 13G/A)

- Amended Statement of Ownership (SC 13G/A)

A3K8U3 Discussion

Your Recent History